CLINICAL_TRIALS
trial_result
· 2020-12-21
Clinical Trial Update: Study of BIIB092 in Participants With Progressive Supranuclear Palsy [Phase 2]
Summary
Phase 2 study of BIIB092 in progressive supranuclear palsy was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Supranuclear Palsy, Progressive | Phase 2 | Status: TERMINATED | Results posted: 2020-12-21